Premium Nahrungsergänzungsmittel | artgerecht

Thyroid Autoantibodies – Definition & Clinical Role

Thyroid autoantibodies are immune system antibodies that mistakenly target the body's own thyroid tissue, playing a key role in autoimmune thyroid diseases.

Regular tips about health Regular tips about health

Things worth knowing about "Thyroid Autoantibodies"

Thyroid autoantibodies are immune system antibodies that mistakenly target the body's own thyroid tissue, playing a key role in autoimmune thyroid diseases.

What Are Thyroid Autoantibodies?

Thyroid autoantibodies are antibodies produced by the immune system that mistakenly attack the body's own thyroid gland. Under normal circumstances, antibodies protect the body against pathogens. In autoimmune conditions, however, the immune system loses its ability to distinguish between self and non-self, leading it to attack the body's own tissues. The thyroid gland is one of the most commonly affected organs in such autoimmune reactions.

Types of Thyroid Autoantibodies

There are several clinically relevant types of thyroid autoantibodies:

TPO Antibodies (Anti-TPO, thyroid peroxidase antibodies): These target the enzyme thyroid peroxidase, which is essential for thyroid hormone production. Elevated TPO antibodies are characteristic of Hashimoto thyroiditis and Graves disease.
Thyroglobulin Antibodies (Anti-Tg, Anti-TG): These target thyroglobulin, a storage protein of the thyroid gland. They are also found in Hashimoto thyroiditis and are used to monitor patients after thyroid cancer treatment.
TSH Receptor Antibodies (TRAb, TRAK): These bind to the TSH receptor on thyroid cells. Stimulating TRAb lead to excessive thyroid hormone production and are the hallmark of Graves disease. Blocking TRAb, on the other hand, can cause hypothyroidism.

Associated Conditions

Elevated thyroid autoantibodies are primarily associated with the following conditions:

Hashimoto Thyroiditis: The most common autoimmune thyroid disease, in which chronic inflammation destroys thyroid tissue and can lead to hypothyroidism (underactive thyroid). Elevated TPO and anti-Tg antibodies are typical findings.
Graves Disease: An autoimmune condition in which stimulating TSH receptor antibodies trigger hyperthyroidism (overactive thyroid). A typical sign is exophthalmos (protruding eyes).
Postpartum Thyroiditis: A temporary inflammation of the thyroid gland following childbirth, often associated with elevated TPO antibodies.
Thyroid Carcinoma: Elevated anti-Tg antibodies may affect follow-up monitoring after thyroid cancer treatment.

Diagnosis and Laboratory Values

Thyroid autoantibodies are measured through a blood test. Results are typically reported in international units per milliliter (IU/ml) or units per milliliter (U/ml). Reference ranges may vary between laboratories, but general guidelines are as follows:

TPO antibodies: below 35 IU/ml (values above this are considered elevated)
Thyroglobulin antibodies: below 40 IU/ml
TSH receptor antibodies (TRAb): below 1.75 IU/l

Elevated antibody levels alone are not proof of active disease. They must always be interpreted in the clinical context alongside other thyroid parameters such as TSH, fT3, and fT4, as well as a thyroid ultrasound.

Clinical Significance and Disease Course

The presence of thyroid autoantibodies, particularly TPO antibodies, increases the risk of developing a manifest thyroid dysfunction. However, antibody levels may remain elevated for many years without any symptoms occurring. Regular monitoring is therefore advisable. In pregnant women, elevated thyroid autoantibodies are of particular importance, as they can increase the risk of miscarriage, preterm birth, and postpartum thyroiditis.

Treatment

There is currently no specific therapy aimed directly at reducing thyroid autoantibody levels. Treatment is directed at the underlying condition and thyroid function:

Hypothyroidism in Hashimoto thyroiditis: Replacement therapy with levothyroxine (L-thyroxine), a synthetic thyroid hormone.
Hyperthyroidism in Graves disease: Antithyroid drugs (e.g., methimazole), radioiodine therapy, or surgical removal of the thyroid gland.
Selenium supplementation: Studies suggest that selenium supplementation may reduce TPO antibody levels in Hashimoto thyroiditis. Routine recommendations apply primarily in regions with confirmed selenium deficiency.

References

Pearce EN, Farwell AP, Braverman LE. Thyroiditis. New England Journal of Medicine. 2003;348(26):2646-2655.
Garber JR et al. Clinical Practice Guidelines for Hypothyroidism in Adults. Thyroid. 2012;22(12):1200-1235.
World Health Organization (WHO). Thyroid disorders - global guidelines and clinical management. WHO Press, Geneva.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.